The relationship between echocardiographic parameters and brain natriuretic peptide levels in acute and chronic mitral regurgitation

Turk Kardiyoloji Dernegi Arsivi

Volumn 39, Issue 3, 2011, Pages 191-197

  Kargin, Ramazan ^a   Esen, Özlem ^a,b   Pala, Selçuk ^a   Akçakoyun, Mustafa ^a   Emiroǧlu, Yunus ^a   Arslan, Kürşat ^a   Aung, Soe Moe ^a   Barutçu, Irfan ^a,c   Esen, Ali Metin ^a   Özdemir, Nihal ^a  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^b MEMORIAL HOSPITAL   (Turkey)

^c Avicenna Hospital   (Turkey)

Author keywords

Echocardiography; Mitral valve insufficiency; Natriuretic peptide, brain; Ventricular function, left

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PROTEIN BLOOD LEVEL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 79959937908     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2011.01273     Document Type: Article

References (29)

1. Rosenhek R, Rader F, Klaar U, Gabriel H, Krejc M, Kalbeck D, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006;113:2238-44.
2. Grigioni F, Avierinos JF, Ling LH, Scott CG, Bailey KR, Tajik AJ, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 2002;40:84-92.
3. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999;99:400-5. (Pubitemid 29051266)
4. Carabello BA. Progress in mitral and aortic regurgitation. Prog Cardiovasc Dis 2001;43:457-75. (Pubitemid 32611232)
5. Otto CM. Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med 2001;345:740-6.
6. Keeffe BG, Otto CM. Mitral regurgitation. Minerva Cardioangiol 2003;51:29-39. (Pubitemid 36565187)
7. Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC Jr, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005;111:2391-7. (Pubitemid 40647075)
8. Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003;41:2280-7. (Pubitemid 36724280)
9. Mayer SA, De Lemos JA, Murphy SA, Brooks S, Roberts BJ, Grayburn PA. Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation. Am J Cardiol 2004;93:1002-6. (Pubitemid 38479454)
10. D'Cruz IA, Shroff SG, Janicki JS, Jain A, Reddy HK, Lakier JB. Differences in the shape of the normal, cardiomyopathic, and volume overloaded human left ventricle. J Am Soc Echocardiogr 1989;2:408-14.
11. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94. (Pubitemid 26415815)
12. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart 2001;86:638-42. (Pubitemid 33086878)
13. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 1998;135:21-8. (Pubitemid 28073054)
14. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9.
15. Tang WH, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003;108:2964-6. (Pubitemid 37553562)
16. Detaint D, Messika-Zeitoun D, Chen HH, Rossi A, Avierinos JF, Scott C, et al. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation. Am J Cardiol 2006;97:1029-34.
17. Benhalima B, Cohen A, Chauvel C, Abergel E, Albo C, Elhadad S, et al. Morphological study by transesophageal echocardiography and clinical aspects of ruptured chordae tendineae in the elderly. Arch Mal Coeur Vaiss 1995;88:345-52. [Abstract]
18. Mintz GS, Kotler MN, Segal BL, Parry WR. Two-dimensional echocardiographic recognition of ruptured chordae tendineae. Circulation 1978;57:244-50. (Pubitemid 8277776)
19. Kaymaz C, Özdemir N, Özkan M. Differentiating clinical and echocardiographic characteristics of chordal rupture detected in patients with rheumatic mitral valve disease and floppy mitral valve: impact of the infective endocarditis on chordal rupture. Eur J Echocardiogr 2005;6:117-26. (Pubitemid 40331487)
20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
21. Gutman J, Wang YS, Wahr D, Schiller NB. Normal left atrial function determined by 2-dimensional echocardiography. Am J Cardiol 1983;51:336-40. (Pubitemid 13179407)
22. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802. (Pubitemid 37391035)
23. Farias CA, Rodriguez L, Garcia MJ, Sun JP, Klein AL, Thomas JD. Assessment of diastolic function by tissue Doppler echocardiography: comparison with standard transmitral and pulmonary venous flow. J Am Soc Echocardiogr 1999;12:609-17. (Pubitemid 29387618)
24. Brookes CI, Kemp MW, Hooper J, Oldershaw PJ, Moat NE. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 1997;6:608-12.
25. Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417-23. (Pubitemid 26382502)
26. Ray SG. Natriuretic peptides in heart valve disease. Heart 2006;92:1194-7.
27. Hosoda K, Nakao K, Mukoyama M, Saito Y, Jougasaki M, Shirakami G, et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 1991;17:1152-5.
28. Yusoff R, Clayton N, Keevil B, Morris J, Ray S. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation. Am J Cardiol 2006;97:1498-501.
29. Ribeiro MC, Markman Filho B, Santos CC, Mello CP. Clinical and functional characterisation of rheumatic mitral regurgitation in children and adolescents including the brain natriuretic peptide. Cardiol Young 2010;20:66-72.